Valuation (33%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.06 | N/A |
PEG Ratio (TTM) | 0.00 | N/A |
P/S Ratio (TTM) | 23.63 | N/A |
P/B Ratio (TTM) | 0.33 | N/A |
P/FCF Ratio (TTM) | -0.10 | N/A |
Price to 5YR AVG Earnings Ratio | -0.02 | N/A |
Price to 5YR AVG FCF Ratio | -0.05 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -210.31% | N/A |
ROE (TTM) | -199.89% | N/A |
Net Profit Margin (TTM) | -36,689.40% | N/A |
ROIC 5YR AVG | -107.22% | N/A |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -17.18% | 35.30% | 23.40% |
Revenue | 87.46% | -12.20% | -16.64% |
Net Income | -17.63% | -47.88% | -30.61% |
Cash Flow | -2.04% | -40.29% | -28.95% |
Health (32%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.58 | N/A |
Quick Ratio (TTM) | 1.53 | N/A |
D/E Ratio (TTM) | 0.12 | N/A |
Interest Coverage (TTM) | N/A | N/A |
Piotroski F-Score | 2 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | -0.87 | N/A |
Shares Outstanding Growth 5YR AVG | 111.64% | N/A |